Literature DB >> 7576566

Interobserver agreement for tumour type, grade of differentiation and stage in endometrial carcinomas.

L Nedergaard1, M Jacobsen, J E Andersen.   

Abstract

The histopathologic evaluation plays a major role in subdividing endometrial carcinomas into treatment groups. We have evaluated the interobserver agreement regarding tumour type, grade of differentiation, stage and stage I low and high risk cases. A total of 177 cases of endometrial carcinoma in which a hysterectomy and a bilateral salpingo-oophorectomy were performed, were reviewed by three examiners. A variety of features including tumour type, architectural grade, nuclear grade, FIGO grade, and spread/metastases were recorded, and the FIGO stage was determined. Using two different definitions low and high risk groups in stage I tumours were separated. A kappa value was calculated for each of the various parameters. The current study showed a good strength of agreement for tumour type, myometrial invasion, spread/metastases, and FIGO stage (kappa 0.62-1.00). For two of the examiners good agreement was found as to architectural grade (kappa 0.71) while the kappa value for nuclear grade was lower (0.56). As nuclear grading is included in the revised FIGO recommendation a precise definition of nuclear atypia is needed. In stage I tumours very good agreement was demonstrated as to the defined low and high risk group (Kappa 0.64-0.86).

Entities:  

Mesh:

Year:  1995        PMID: 7576566     DOI: 10.1111/j.1699-0463.1995.tb01399.x

Source DB:  PubMed          Journal:  APMIS        ISSN: 0903-4641            Impact factor:   3.205


  5 in total

1.  Interobserver Variability in the Diagnosis of Uterine High-Grade Endometrioid Carcinoma.

Authors:  Sumi Thomas; Yaser Hussein; Sudeshna Bandyopadhyay; Michele Cote; Oudai Hassan; Eman Abdulfatah; Baraa Alosh; Hui Guan; Robert A Soslow; Rouba Ali-Fehmi
Journal:  Arch Pathol Lab Med       Date:  2016-05-03       Impact factor: 5.534

2.  Prognostic impact of histological review of high-grade endometrial carcinomas in a large Danish cohort.

Authors:  Marie Boennelycke; Elke E M Peters; Alicia Léon-Castillo; Vincent T H B M Smit; Tjalling Bosse; Ib Jarle Christensen; Gitte Ørtoft; Claus Høgdall; Estrid Høgdall
Journal:  Virchows Arch       Date:  2021-06-11       Impact factor: 4.064

3.  Reproducibility of measurement of myometrial invasion in endometrial carcinoma.

Authors:  Louis J M van der Putten; Koen van de Vijver; Carla Bartosch; Ben Davidson; Sonia Gatius; Xavier Matias-Guiu; W Glenn McCluggage; Gemma Toledo; Anneke A M van der Wurff; Johanna M A Pijnenborg; Leon F A G Massuger; Johan Bulten
Journal:  Virchows Arch       Date:  2016-10-27       Impact factor: 4.064

4.  MRI-assessed tumor-free distance to serosa predicts deep myometrial invasion and poor outcome in endometrial cancer.

Authors:  Julie Andrea Dybvik; Kristine E Fasmer; Sigmund Ytre-Hauge; Jenny Hild Aase Husby; Øyvind O Salvesen; Ingunn Marie Stefansson; Camilla Krakstad; Jone Trovik; Ingfrid S Haldorsen
Journal:  Insights Imaging       Date:  2022-01-08

5.  Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative.

Authors:  Ellen Stelloo; Tjalling Bosse; Remi A Nout; Helen J MacKay; David N Church; Hans W Nijman; Alexandra Leary; Richard J Edmondson; Melanie E Powell; Emma J Crosbie; Henry C Kitchener; Linda Mileshkin; Pamela M Pollock; Vincent T Smit; Carien L Creutzberg
Journal:  Mod Pathol       Date:  2015-02-27       Impact factor: 7.842

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.